Not actual patient.
Not actual patient.
PEDMARK is given as a 15-minute infusion
If PEDMARK is given too soon after cisplatin infusion, it may impact how well cisplatin works.
If PEDMARK is given more than 6 hours after cisplatin infusion, it may not work to protect your child’s hearing.
A child should not get PEDMARK if the next scheduled cisplatin infusion will start in less than 10 hours.
The doctor will give medication to help prevent nausea and vomiting prior to the PEDMARK infusion.
Fennec HEARS™ is your single source for both financial and patient support. Call 1-833-7PEDMARK.
Find helpful tools for you or your child.
Please see full Prescribing Information, including Patient Information, for PEDMARK.
PEDMARK is a prescription medicine used to decrease the risk of hearing loss in children 1 month of age and older who are receiving cisplatin for solid tumors (cancer) that have not spread to other parts of the body.
It is not known if PEDMARK is safe and effective when given after cisplatin infusions longer than 6 hours.
It is not known if PEDMARK is safe and effective in children less than 1 month of age. PEDMARK is not recommended in children younger than 1 month of age.